Page 21 - Compugen News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Compugen (NASDAQ:CGEN – Get Rating) and Graphite Bio (NASDAQ:GRPH – Get Rating) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their risk, dividends, profitability, earnings, valuation, institutional ownership and analyst recommendations. Profitability This table compares Compugen and Graphite Bio’s net margins, […]

Compugen Ltd. (NASDAQ:CGEN – Get Rating) has received a consensus rating of “Moderate Buy” from the seven analysts that are currently covering the firm, Marketbeat Ratings reports. One analyst has rated the stock with a sell rating, one has given a hold rating and five have assigned a buy rating to the company. The average […]

Eagle Rock Investment Company LLC raised its holdings in shares of Compugen Ltd. (NASDAQ:CGEN – Get Rating) by 100.0% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 70,000 shares of the biotechnology company’s stock after purchasing an additional 35,000 […]

This guide looks at the best stocks under $1 in 2023 that have the potential to bring you profit. We also examine the leading trading platforms.

/PRNewswire/ -- Compugen Ltd. (NASDAQ: CGEN) (TASE: CGEN), a clinical-stage cancer immunotherapy company and a pioneer in computational target discovery, today...